医学分子生物学杂志 ›› 2024, Vol. 21 ›› Issue (1): 86-92.doi: 10.3870/j.issn.1672-8009.2024.01.014

• 综述 • 上一篇    

G 蛋白信号转导调节因子在癌症中的新兴作用 #br#

  

  1. 1珠海市妇幼保健医院乳腺外科 广东省珠海市, 519000 2中山大学附属第五医院病理科 广东省珠海市, 519000
  • 出版日期:2024-01-31 发布日期:2024-03-07

Emerging Roles of Regulators of G Protein Signaling Proteins in Cancer #br#

  1. 1Department of Breast Surgery, Zhuhai Maternal and Child Health Care Hospital, Zhuhai, Guangdong, 519000, China 2Department of Pathology, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, 519000, China
  • Online:2024-01-31 Published:2024-03-07

摘要: G 蛋白偶联受体 (G protein-coupled receptors, GPCRs) 是一类重要的细胞膜表面 7 次跨膜蛋白受体超家族, 可将多种分子外刺激, 包括激素离子有机分子和光转化为细胞内 效应器”, 目前普遍认为 GPCR 通路是致癌信号传输的关键路径, G 蛋白信号转导调节因子 ( regulators of G protein signaling, RGS) 蛋白家族是调控 GPCR 通路的关键蛋白。 RGS 家族的许多分子在恶性肿瘤的发生和发展中具有重要作用, 是癌症诊断治疗和预后的重要靶点文章综述了近年来 RGS 家族在肿瘤发生发展中的重要作用, 阐释了 RGS 在肿瘤微环境中的独特作用, 总结了 RGS 作用于肿瘤的一般规律, 最后介绍一些靶向 RGS蛋白的治疗癌症的方法

关键词: G 蛋白调节剂, 癌症, 治疗, 肿瘤微环境

Abstract: G protein coupled receptors (GPCRs) belong to a superfamily of cell surface receptors, which activate heterotrimeric G proteins that transduce a vast variety of extracellular stimuli, including hormones, ions, organic molecules, and light into the intracellular “effectors” to generate cellular responses. It is widely accepted that GPCR signaling pathways have emerged as the critical mediators for oncogenic signaling. Regulators of G protein signaling ( RGS) proteins are key proteins in GPCR signaling regulations. Many members in the RGS family play pivotal roles in the development of malignant tumors and serve as important targets for cancer diagnosis, treatment and prognosis. This review introduces the structural features, biological effects, and regulatory mechanisms of the RGS family, highlights the recent studies of specific roles of RGS proteins in multiple cancer types, and further explains the general characteristics of RGS in Pan-cancer. In addition, this review summarizes the unique role of RGS in tumor microenvironments as well as the current efforts made on cancer therapy via targeting RGS proteins.

Key words: regulators of G-protein signaling, cancer, treatment, tumor microenvironment